Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (28 quarters reported)
$58.1M in Q4 2016 → $11.8M now. Hover for any quarter.
As reported for the quarter ended September 30, 2023. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| S Skillz Inc | 49.7% | Unchanged | 1,145,492 | $5.84M |
| CB Coherus Biosciences Inc | 18.1% | New | 568,408 | $2.13M |
| Spero Therapeutics Inc | 13.9% | Unchanged | 1,353,303 | $1.64M |
| Snap Inc | 11.4% | Unchanged | 150,160 | $1.34M |
| Synlogic Inc | 4.2% | New | 176,798 | $497K |
| Intellia Therapeutics Inc | 2.7% | Unchanged | 10,000 | $316K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2023 · filed November 13, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SO Surface Oncology Inc | Exited | −2,945,453 | −$2.56M | — |
| CB Coherus Biosciences Inc | New | +568,408 | +$2.13M | 18.1% |
| Synlogic Inc | Exited | −2,651,963 | −$1.14M | — |
| Synlogic Inc | New | +176,798 | +$497K | 4.2% |
quarter ended June 30, 2023 · filed August 08, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| S Skillz Inc | Trimmed | −21,764,367 | −$198M | 57.0% |
| Spero Therapeutics Inc | Trimmed | −23,665 | −$34.3K | 10.7% |
quarter ended March 31, 2023 · filed May 08, 2023
No position changes this quarter.
quarter ended December 31, 2022 · filed January 31, 2023
No position changes this quarter.
quarter ended September 30, 2022 · filed November 10, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Cogent Biosciences Inc | Exited | −466,832 | −$4.21M | — |
quarter ended June 30, 2022 · filed August 11, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Cogent Biosciences Inc | Trimmed | −450,000 | −$4.06M | 9.6% |
quarter ended March 31, 2022 · filed May 12, 2022
No position changes this quarter.
quarter ended December 31, 2021 · filed January 27, 2022
No position changes this quarter.
Loading...
